Keyphrases
Carboplatin
100%
Paclitaxel
100%
Non-small Cell Lung Cancer (NSCLC)
100%
Protein Expression Level
100%
Thymidylate Synthase
100%
Pemetrexed
36%
Neoadjuvant Chemotherapy
36%
Diagnostic Biopsy
27%
Chemotherapy
18%
Non-small Cell Lung Cancer Patients
18%
H-score
18%
Primary Tumor
18%
Resection Specimen
18%
Surgical Resection
9%
Second-line Treatment
9%
Preoperative Chemotherapy
9%
Serial Sampling
9%
Re-biopsy
9%
Resection
9%
Intratumoral Heterogeneity
9%
Expression Change
9%
Predictive Marker
9%
Expression Analysis
9%
Treatment Efficacy
9%
Immunohistochemisty
9%
Tumor
9%
Biopsy Specimen
9%
Medicine and Dentistry
Paclitaxel
100%
Thymidylate Synthase
100%
Non Small Cell Lung Cancer
100%
Protein Expression
100%
Carboplatin
100%
Biopsy Technique
45%
Neoadjuvant Chemotherapy
36%
Pemetrexed
36%
Surgery
36%
Primary Tumor
27%
Diagnosis
27%
Neoplasm
9%
Biological Marker
9%
Expression Analysis
9%
Predictive Marker
9%
Preoperative Chemotherapy
9%
Neuroscience
Thymidylate Synthase
100%
Carboplatin
100%
Paclitaxel
100%
Protein Expression
100%
Expression Analysis
9%